Lunai Bioworks
LNAI
42 hedge funds and large institutions have $4.17M invested in Lunai Bioworks in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 18 reducing their positions, and 33 closing their positions.
0.06% less ownership
Funds ownership: 0.17% → 0.1% (-0.06%)
30% less funds holding
Funds holding: 60 → 42 (-18)
55% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 33
61% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 18
65% less capital invested
Capital invested by funds: $12M → $4.17M (-$7.79M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$745K |
| 2 |
Jane Street
New York
|
+$312K |
| 3 |
Goldman Sachs
New York
|
+$144K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$108K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$79.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.63M |
| 2 |
State Street
Boston,
Massachusetts
|
-$574K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$472K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$257K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$216K |
LNAI Hedge Fund Activity: Q2 2025 in Review
42 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2025, worth a combined $4.17M — down 65% from $12M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of LNAI and 15 opened new positions — a net loss of 18 holders — while 18 trimmed existing stakes and 7 added.
The largest buyer was Millennium Management, adding an estimated $745K. The largest seller was BlackRock, cutting an estimated $1.63M.
- 42 institutional investors held Lunai Bioworks (LNAI) as of Q2 2025, down from 60 in Q1 2025.
- Funds reported $4.17M of Lunai Bioworks stock for Q2 2025, down 65% quarter-over-quarter.
- 15 funds opened new Lunai Bioworks positions in Q2 2025 and 33 closed out, a net change of -18 holders.
- The largest Lunai Bioworks buyer in Q2 2025 was Millennium Management, an estimated $745K added.
- The largest Lunai Bioworks seller in Q2 2025 was BlackRock, an estimated $1.63M sold.
Based on aggregated 13F filings for Q2 2025.